Xtant Medical Holdings Inc XTNT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Xtant Medical Reports Third Quarter 2026 Financial Results and Announces Board-led Strategic Review Process
Xtant Medical to Announce Third Quarter 2026 Financial Results on November 16, 2026
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market
Trading Information
- Previous Close Price
- $0.22
- Day Range
- $0.20–0.25
- 52-Week Range
- $0.17–0.84
- Bid/Ask
- $0.19 / $0.24
- Shares Outstanding
- 140.45M
- Market Cap
- $29.49M
- Volume/Avg
- 257,127 / 2M
Key Statistics
- Price/Earnings (Normalized)
- 17.46
- Price/Sales
- 0.31
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.21%
Company Profile
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 151
- Website
- http://www.xtantmedical.com
Valuation
Metric | XTNT |
|---|---|
Price/Earnings (Normalized) | 17.46 |
Price/Book Value | 0.81 |
Price/Sales | 0.31 |
Price/Cash Flow | — |
Price/Earnings
XTNT
Financial Strength
Metric | XTNT |
|---|---|
Quick Ratio | 0.88 |
Current Ratio | 2.00 |
Interest Coverage | −4.93 |
Quick Ratio
XTNT
Profitability
Metric | XTNT |
|---|---|
Return on Assets (Normalized) | −13.87% |
Return on Equity (Normalized) | −26.45% |
Return on Invested Capital (Normalized) | −14.70% |
Return on Assets
XTNT
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|rG<g<<% | LOCK|lh&Fx | $180B | |||
| Medtronic PLC MDT | LOCK|FP&K!F# | LOCK|^$>V$ | $129B | |||
| Stryker Corp SYK | LOCK|#<b<ct@ | LOCK|<?l | $119B | |||
| Boston Scientific Corp BSX | LOCK|>WwbDGb | LOCK|rKyW# | $62B | |||
| Edwards Lifesciences Corp EW | LOCK|$ztVYch | LOCK|BVkJ | $60B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|m%?>%! | LOCK|yk | $37B | |||
| DexCom Inc DXCM | LOCK|?@GT&Q%> | LOCK|Fsvl | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|&X< | LOCK|Pf | $29B | |||
| Steris PLC STE | LOCK|CxS<>> | LOCK|Qcs#@ | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|g&gMs<Gl | LOCK|jw | $19B |